The Promising Nanocarrier for Doxorubicin and siRNA Co-delivery by PDMAEMA-based Amphiphilic Nanomicelles
Abstract
Synergistic effects of anticancer drug and siRNA have displayed superior advantages for cancer therapy. Herein, we deeply analyzed the feasibility that whether doxorubicin (DOX) and siRNA could be co-delivered by mPEG-PCL-graft-PDMAEMA (PECD) micelles, which mediated excellent DNA/siRNA delivery in vitro and in vivo reported in our previous work. DOX-loaded NPs (PECD-D) were developed by nanoprecipitation technology and exhibited high drug loading content (DLC, 9.5%). In vitro cytotoxicity study in MDA-MB-231 cells, PECD-D treated groups had lower IC50 compared to free DOX groups (F-DOX) at different transfection time (24, 48, and 72h), which maybe attribute to its high cellular uptake and endosomal escape properties. The speculation was confirmed with the results of drug release profile in acidic media, flow cytometry analysis and confocal images. Futhermore, Cy5 labeled siRNA was introduced in PECD-D micelles (PECD-D/siRNA) to track the behavior of dual-loaded nanodrug in vitro and in vivo. Flow cytometry analysis presented that DOX and siRNA were successfully co-delivered into cells, the positive cells ratio were 94.6 and 99.5%, respectively. Confocal images showed that not only DOX and siRNA existed in cytoplasm, but DOX traversed endosome/lysosome and entered into cell nucleus. For in vivo tumor-targeting evaluation in BALB/c nude mice, both DOX and Cy5-siRNA could be detected in tumor sites after intravenous injection with PECD-D/siRNA formulation. Therefore, we believed that PECD micelles have a potential ability as DOX and siRNA co-delivery carrier for cancer therapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Liposomes and polymeric micelles, representing nanoscale medication distribution methods, have been advanced as a crucial tool for cancer treatment.
“Liposomes and polymeric micelles, representing nanoscale medication distribution methods, have been advanced as a crucial tool for cancer treatment [96,97].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [96]
Cites
1 retracted
Liu, X., Zhou, J., Yu, T., Chen, C., Cheng, Q., Sengupta, K., Huang, Y., Li, H., Liu, C., Wang, Y., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201406764 · Cited by 206 · see citing works
Self-citationRetractedMultidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536 · see citing works
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · see citing works
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,583 · see citing works
Fang, J. Q., Nakamura, H., & Maeda, H. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,573 · see citing works
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · see citing works
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115 · see citing works
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Fröhlich, E. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36111 · Cited by 2,496 · see citing works
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429 · see citing works
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery
Cheng, R., Meng, F., Deng, C., Klok, H., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.084 · Cited by 1,356 · see citing works
Du, J., Du, X., Mao, C., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,177 · see citing works
pH-Sensitive nano-systems for drug delivery in cancer therapy
Liu, J., Huang, Y., Kumar, A., Tan, A., Jin, S., Mozhi, A., & Liang, X.-J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.009 · Cited by 1,121 · see citing works
Self-citationPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,116 · see citing works
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. I. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,080 · see citing works
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881 · see citing works
Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
Maruyama, K. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.003 · Cited by 603 · see citing works
Liang, M., Fan, K., Zhou, M., Duan, D., Zheng, J., Yang, D., Feng, J., & Yan, X. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407808111 · Cited by 507 · see citing works
Self-assembled RNA interference microsponges for efficient siRNA delivery
Lee, J. B., Hong, J., Bonner, D. K., Poon, Z., & Hammond, P. T. (2012) · Nature Materials · doi:10.1038/nmat3253 · Cited by 496 · see citing works
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
Zuckerman, J. E., Choi, C. H. J., Han, H., & Davis, M. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200718109 · Cited by 375 · see citing works
Wei, T., Chen, C., Liu, J., Liu, C., Posocco, P., Liu, X., Cheng, Q., Huo, S., Liang, Z., Fermeglia, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418494112 · Cited by 371 · see citing works
Self-citationLv, S., Tang, Z., Li, M., Lin, J., Song, W., Liu, H., Huang, Y., Zhang, Y., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.034 · Cited by 346 · see citing works
Self-citationPDMAEMA based gene delivery materials
Agarwal, S., Zhang, Y., Maji, S., & Greiner, A. (2012) · Materials Today · doi:10.1016/s1369-7021(12)70165-7 · Cited by 343 · see citing works
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Creixell, M., & Peppas, N. A. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.013 · Cited by 332 · see citing works
Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery
Zhang, Z., Lee, S. H., & Feng, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.018 · Cited by 239 · see citing works
Kudoh, K., Ramanna, M., Ravatn, R., et al. (2000) · PubMed · Cited by 223 · see citing works
Recent advances in delivery of drug–nucleic acid combinations for cancer treatment
Li, J., Wang, Y., Zhu, Y. T., & Oupický, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.010 · Cited by 207 · see citing works
Song, E., Han, W., Li, C., et al. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am502423r · Cited by 199 · see citing works
Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo
Wei, T., Liu, J., Ma, H., Cheng, Q., Huang, Y., Zhao, J., Huo, S., Xue, X., Liang, Z., & Liang, X. (2013) · Nano Letters · doi:10.1021/nl400586t · Cited by 183 · see citing works
Self-citationMa, H., He, C., Cheng, Y., Li, D., Gong, Y., Liu, J., Tian, H., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.045 · Cited by 160 · see citing works
Lee, S. J., Huh, M. S., Lee, S. Y., Min, S., Lee, S., Koo, H., Chu, J., Lee, K. E., Jeon, H., Choi, Y., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201390 · Cited by 158 · see citing works
Wu, X., Wang, Z., Zhu, D., Zong, S., Yang, L., Zhong, Y., & Cui, Y. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am403092m · Cited by 146 · see citing works
Mecerreyes, D., Atthoff, B., Boduch, K. A., Trollsås, M., & Hedrick, J. L. (1999) · Macromolecules · doi:10.1021/ma982005a · Cited by 135 · see citing works
Li, Y., Cheng, Q., Jiang, Q., Huang, Y., Liu, H., Zhao, Y., Cao, W., Ma, G., Dai, F., Liang, X., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.007 · Cited by 124 · see citing works
Self-citationLiu, T., Xue, W., Ke, B., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.040 · Cited by 116 · see citing works
Sosnik, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.002 · Cited by 104 · see citing works
Translating materials design to the clinic
Hubbell, J. A., & Langer, R. (2013) · Nature Materials · doi:10.1038/nmat3788 · Cited by 102 · see citing works
Lin, D., Cheng, Q., Jiang, Q., Huang, Y., Yang, Z., Han, S., Zhao, Y., Guo, S., Liang, Z., & Dong, A. (2013) · Nanoscale · doi:10.1039/c3nr00294b · Cited by 101 · see citing works
Self-citationShahin, M., Soudy, R., Aliabadi, H. M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.019 · Cited by 90 · see citing works
Boyacıoğlu, O., Stuart, C. H., Kulik, G., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.37 · Cited by 88 · see citing works
In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier
Naeye, B., Deschout, H. G., Caveliers, V., Descamps, B., Braeckmans, K., Vanhove, C., Demeester, J., Lahoutte, T., Smedt, S. C. D., & Raemdonck, K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.058 · Cited by 84 · see citing works
Guo, S., Huang, Y., Zhang, W., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.034 · Cited by 84 · see citing works
Self-citationQian, J., Xu, M., Suo, A., Xu, W., Liu, T., Liu, X., Yao, Y., & Wang, H. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.12.018 · Cited by 72 · see citing works
Effects of hydrophobic core components in amphiphilic PDMAEMA nanoparticles on siRNA delivery
Han, S., Cheng, Q., Wu, Y., Zhou, J., Long, X., Wei, T., Huang, Y., Zheng, S., Zhang, J., Deng, L., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.026 · Cited by 70 · see citing works
Self-citationLi, H., Cui, Y., Sui, J., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b03150 · Cited by 70 · see citing works
Lin, D., Huang, Y., Jiang, Q., Zhang, W., Yue, X., Guo, S., Xiao, P., Du, Q., Xing, J., Deng, L., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.089 · Cited by 65 · see citing works
Self-citationMoktan, S., Perkins, E., Kratz, F., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0998 · Cited by 65 · see citing works
SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment
Liu, H., Li, Y., Mozhi, A., Zhang, L., Liu, Y., Xu, X., Xing, J., Liang, X., Ma, G., Yang, J., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.033 · Cited by 64 · see citing works
Self-citationLin, D., Jiang, Q., Cheng, Q., Huang, Y., Huang, P., Han, S., Guo, S., Liang, Z., & Dong, A. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.04.031 · Cited by 54 · see citing works
Self-citationHuang, P., Wang, W., Zhou, J., Zhao, F., Zhang, Y., Liu, J., Liu, J., Dong, A., Kong, D., & Zhang, J. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00962 · Cited by 50 · see citing works
Self-citationCheng, Q., Huang, Y., Zheng, H., Wei, T., Zheng, S., Huo, S., Wang, X., Du, Q., Zhang, X., Zhang, H., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.043 · Cited by 47 · see citing works
Self-citationCordeiro, R. A., Farinha, D., Rocha, N., et al. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201400424 · Cited by 20 · see citing works
Yu, M., Niu, Y., Yang, Y., et al. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am503060n · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The challenge and prospect of mRNA therapeutics landscape
Weng, Y., Li, C., Yang, T., Hu, B., Zhang, M., Guo, S., Xiao, H., Liang, X.-J., & Huang, Y. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107534 · Cited by 417 · see citing works
Self-citationRecent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156 · see citing works
“Liposomes and polymeric micelles, representing nanoscale medication distribution methods, have been advanced as a crucial tool for cancer treatment [96,97].”
Background
- Authors
- Cheng, Q., Du, L., Meng, L., Han, S., Wei, T., Wang, X., Wu, Y., Song, X., Zhou, J., Zheng, S., Huang, Y., Liang, X.-J., Cao, H., Dong, A., & Liang, Z.
- Affiliations
- Peking University (CN)
- Tianjin University (CN)
- National Center for Nanoscience and Technology (CN)
- Corresponding author
- Cheng, Qiang
- ORCID
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-02-11
- Volume
- 8
- Issue
- 7
- Pages
- 4347-4356
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- OpenAlex
- W2264836043
- Cited by
- 85
- References
- 52
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 9 · 2022: 11 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 11 · 2017: 15 · 2016: 6
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Applied Materials & Interfaces (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2012AA022501, 2012ZX09102301-006)
- National Natural Science Foundation of China (31271073, 81273422, 81473128)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- doxorubicin, siRNA, co-delivery, PDMAEMA, mPEG-PCL, nanoprecipitation, endosomal escape, tumor targeting, MDA-MB-231 cells, drug loading, drug release
- MeSH terms
- Animals, Cytoplasm, Doxorubicin, Drug Carriers, HeLa Cells, Humans, Neoplasms, Transfection, Drug Delivery Systems, Xenograft Model Antitumor Assays, RNA, Small Interfering, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
